From Free Entry to Patent Protection: Welfare Implications for the Indian Pharmaceutical Industry
There has been fierce debate over the imposition of stronger intellectual property rights laws for pharmaceutical products in developing countries. This paper uses data from the Indian pharmaceutical industry to develop a structural model of demand, supply and entry. The estimation yields demand and supply parameters that indicate significant heterogeneity among firms both within and across different therapeutic segments. The estimated parameters are used to simulate patent enforcement and price deregulation for 43 drugs, which predicts large losses for consumers and relatively small gains in profits for the global patent holders. © 2011 The President and Fellows of Harvard College and the Massachusetts Institute of Technology.
Volume (Year): 93 (2011)
Issue (Month): 1 (February)
|Contact details of provider:|| Web page: http://mitpress.mit.edu/journals/|
|Order Information:||Web: http://mitpress.mit.edu/journal-home.tcl?issn=00346535|
When requesting a correction, please mention this item's handle: RePEc:tpr:restat:v:93:y:2011:i:1:p:160-178. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Kristin Waites)
If references are entirely missing, you can add them using this form.